Navigation Links
H1N1 Flu Is Raging in Britain; Could U.S. Be Next?
Date:1/20/2011

By Amanda Gardner
HealthDay Reporter

THURSDAY, Jan. 20 (HealthDay News) -- This winter, influenza seems to be behaving very differently depending on what side of the Atlantic you're on.

As of last week, for example, H1N1 ("swine") flu still predominated in Britain, where 112 people have died, hospitals are filling up with very ill flu patients, and some doctors report running out of vaccine, according to the BBC. Experts are concerned that the virus -- known as 2009 H1N1 -- could create a similar situation in mainland Europe.

However, in the United States, clinicians are only now starting to see cases of the flu -- mostly of the traditional, H3N2 variety -- and the atmosphere is much more calm. Vaccine is plentiful and much of it is going unused.

Still, with modern air travel allowing viruses to spread easily around the globe, could the British flu experience travel to America?

That question remains unanswered. According to experts, it's still relatively early in the flu season and anything could happen.

In Rochester, N.Y., "we're getting a mix of a little bit of H1N1 but not much. We're seeing more of H3N2 and some influenza B, so all three players are in the pot," said Dr. Edward Walsh, an infectious diseases expert and professor of medicine at the University of Rochester Medical Center. "As to which one is going to be dominant, we're waiting and seeing. I don't think we can predict that yet."

Walsh's reports mirror those of the U.S. Center for Disease Control and Prevention, which says -- for the week ending Jan. 8, 2011 -- about 8 percent of samples tested were 2009 H1N1 and 31.5 percent the H3N2 variety.

Still, H3N2's dominance "could change very quickly," Walsh said.

One theory as to why H1N1 hasn't made a strong showing in the United States this year is that many Americans gained immunity last season.

"So much of the U.S. population was vaccinated against H1N1 last year and so much immunity developed as the thing spread like wildfire, that's the reason the predominate strain is H3N2 -- it's all about immunity," said Dr. Marc Siegel, an associate professor of medicine at New York University in New York City.

But a comeback for the strain -- which is typically more serious for younger patients -- isn't out of the question.

H1N1 "appeared at a distinctly odd time in its initial debut in April/May of 2009 [flu season usually ends in March or even a little earlier] so it's obviously got an unpredictable course as to when it's going to actually attack a population," noted Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City.

"What will happen in any individual country or area, we just don't know. It's impossible to estimate," added Dr. John Carpenter, professor of internal medicine at Texas A&M Health Science Center College of Medicine and division director of infectious diseases at Scott & White in Temple. "We just don't know if it will come over here. If somebody hops on a plane with it and comes over here..."

But, he added, "if it jumps to Europe, there's a better chance it will jump here."

And experts aren't ruling out the possibility that there could be regional variations in the United States, with different strains leading in different areas.

"You don't always get the exact same thing in every country or even within every region," Walsh said.

In the meantime, people should not underestimate the potentially deadly nature of H3N2, which tends to hit the elderly the hardest. Siegel expects to see more elderly patients than last year -- and more deaths. H3N2 tends to cause more pneumonia and other complications than other forms of flu, he said.

"Last year, there were 10,000 deaths compared to the normal 34,000 [from flu]," he said. If H3N2 continues to predominate, "the age distribution of deaths this year will be back to the elderly," Seigel said.

Whatever strain ends up as the predominant one, this year's vaccine -- which contains H1N1, H3N2 and Influenza B -- should help protect Americans.

"It's not definitive yet but it's reasonable to think it will be a good match," said Walsh.

According to the Associated Press, this has been a banner season for flu vaccine production in the United States, with 160 million doses already made. So while Britain is running short on vaccinations, the U.S. supply should hold up to any spikes in demand.

The CDC recommends that all people aged 6 months and over get the seasonal flu shot, with priority given to pregnant women, young children, the elderly and certain other groups.

More information

There's more on the seasonal flu vaccine at the U.S. Centers for Disease Control and Prevention.

SOURCES: Marc Siegel, M.D., associate professor, medicine, New York University, New York City; Edward Walsh, M.D., professor, medicine, University of Rochester Medical Center; John Carpenter, M.D., professor of internal medicine, Texas A&M Health Science Center College of Medicine and division director of infectious diseases, Scott & White, Temple; Len Horovitz, pulmonary specialist, Lenox Hill Hospital, New York City; BBC, Associated Press


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Encouraging findings suggest new avenues for treating liver disease in overweight Americans
2. Studies offer encouraging data on preventing Crohns disease recurrence
3. KidsPlay Unplugged, LLC Launches Website; Announces Production of Upcoming DVD's Encouraging Children to Engage in Free Spirited and Imaginary Play
4. Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study
5. Novel paclitaxel formulation encouraging for treating advanced lung cancer
6. Residency match results not encouraging for adults needing primary care
7. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
8. Bick Group Launches Leveraging Cloud Computing Within the Modern Data Center Webinar Series
9. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
10. Genetics Could Play Role in Teen Drinking
11. Obesity in horses could be as high as in humans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
H1N1 Flu Is Raging in Britain; Could U.S. Be Next?
(Date:12/8/2016)... Somerset, N.J. (PRWEB) , ... December 08, 2016 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... The PSCI was set up in 2006 as a non-profit organization to unite ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Hamilton County, is embarking on a charity drive ... specializes in finding new homes for orphaned or neglected senior dogs in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned ... and around the Hancock County area, is announcing the launch of a charity effort ... The Hancock County Food Pantry has worked for more than 30 years to meet ...
(Date:12/7/2016)... ... , ... Students attending Envision’s summer 2017 National Youth ... experience in an emergency medical simulation, When Care is Hours Away. This dynamic ... skills that are critical success in a future career and beyond. , The ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)...  Pennsylvania Physician General Dr. Rachel Levine ... Gary Tennis released safe prescribing guidelines ... developed with the help of a task force. ... frequently prescribed for anxiety or insomnia," said Dr. ... pain medications, benzodiazepines pose a significant risk for ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: